Literature DB >> 1996638

Characterization of a gastrin-type receptor on rabbit gastric parietal cells using L365,260 and L364,718.

S Roche1, J P Bali, J C Galleyrand, R Magous.   

Abstract

Previous studies have demonstrated that gastrin and the COOH-terminal octapeptide of cholecystokinin (CCK-8) stimulated in vitro acid secretion from isolated rabbit gastric parietal cells. Both peptides bind to receptor sites located on these cells and induce an increase in phosphoinositide turnover and an uptake of [14C]aminopyrine ([14C]AP) with the same efficacy and potency. In the present study, we used the 3-(benzoylamino)-benzodiazepine analogue L365,260 and the 3-(acylamino)-benzodiazepine analogue L364,718 to investigate what type of receptor (gastrin type or CCK-A type) is involved in the regulation of the H+ secretory activity of the rabbit parietal cell. Neither L365,260 nor L364,718 alone caused stimulation of [3H]inositol phosphates ([3H]InsP) production. Each analogue inhibited 125I-labeled gastrin or 125I-CCK-8 binding to parietal cells and gastrin- or CCK-8-induced [3H]InsP production and [14C]AP accumulation. In all cases, L365,260 was approximately 70-100 times more potent than L364,718 (IC50 approximately 2-4 nM for L365,260 and approximately 0.2-0.4 microM for L364,718). Nevertheless, each antagonist displayed the same potency to inhibit the effects of gastrin or CCK-8. These results demonstrate that gastrin and CCK-8 interact with the same "gastrin-type" receptor on parietal cells. Moreover, L365,260 behaves as a competitive antagonist of the action of gastrin on parietal cells. Gastrin induces a rise in the levels of inositol 1,4,5-trisphosphate [Ins(1,4,5)P3] and inositol 1,3,4,5-tetrakisphosphate [Ins(1,3,4,5)P4] within the first seconds after parietal cell stimulation. The fact that L365,260 (10 nM) totally suppressed the gastrin-induced formation of Ins(1,4,5)P3 and Ins(1,3,4,5)P4 suggests the involvement of these isomers in the mediation of acid secretion through gastrin receptor activation.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1996638     DOI: 10.1152/ajpgi.1991.260.2.G182

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  6 in total

1.  Analysis of the variation in the action of L-365,260 at CCKB/gastrin receptors in rat, guinea-pig and mouse isolated gastric tissue assays.

Authors:  S P Roberts; E A Harper; G F Watt; V P Gerskowitch; R A Hull; N P Shankley; J W Black
Journal:  Br J Pharmacol       Date:  1996-08       Impact factor: 8.739

Review 2.  The production and role of gastrin-17 and gastrin-17-gly in gastrointestinal cancers.

Authors:  Jeffrey Copps; Richard F Murphy; Sándor Lovas
Journal:  Protein Pept Lett       Date:  2009       Impact factor: 1.890

3.  Cholecystokinin type B receptor antagonist PD-136,450 is a partial secretory agonist in the stomach and a full agonist in the pancreas of the rat.

Authors:  A Schmassmann; A Garner; B Flogerzi; M Y Hasan; M Sanner; L Varga; F Halter
Journal:  Gut       Date:  1994-02       Impact factor: 23.059

4.  Expression cloning and characterization of the canine parietal cell gastrin receptor.

Authors:  A S Kopin; Y M Lee; E W McBride; L J Miller; M Lu; H Y Lin; L F Kolakowski; M Beinborn
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-15       Impact factor: 11.205

5.  Receptor-operated Ca2+ channels in gastric parietal cells: gastrin and carbachol induce Ca2+ influx in depleting intracellular Ca2+ stores.

Authors:  S Roche; J P Bali; R Magous
Journal:  Biochem J       Date:  1993-01-01       Impact factor: 3.857

Review 6.  Distinguishing multiple CCK receptor subtypes. Studies with guinea pig chief cells and transfected human CCK receptors.

Authors:  R T Jensen; J M Qian; J T Lin; S A Mantey; J R Pisegna; S A Wank
Journal:  Ann N Y Acad Sci       Date:  1994-03-23       Impact factor: 5.691

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.